Patents Assigned to NeXstar Pharmaceuticlas, Inc.
  • Patent number: 6229002
    Abstract: This invention discloses a method for preparing a complex comprised of a PDGF Nucleic Acid Ligand and a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound by identifying a PDGF Nucleic Acid Ligand by SELEX methodology and associating the PDGF Nucleic Acid Ligand with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further discloses Complexes comprising one or more PDGF Nucleic Acid Ligands in association with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further includes a Lipid construct comprising a PDGF Nucleic Acid Ligand or Complex and methods for making the same.
    Type: Grant
    Filed: December 16, 1997
    Date of Patent: May 8, 2001
    Assignee: NeXstar Pharmaceuticlas, Inc.
    Inventors: Nebojsa Janjic, Larry Gold
  • Patent number: 5858660
    Abstract: This invention discloses a method for coevolving products from two or more reactants, along with the nucleic acid that can facilitate the reaction for making the products. The invention further discloses the products and facilitating nucleic acids produced by said method.
    Type: Grant
    Filed: March 20, 1996
    Date of Patent: January 12, 1999
    Assignee: NeXstar Pharmaceuticlas, Inc.
    Inventors: Bruce Eaton, Larry Gold